Diabetes mellitus as a multisystem disease: understanding subtypes, complications, and the link with steatotic liver diseases in humans
Authors:
Open Access
- 1 August 2025
- journal article
- review article
- Published by Springer Nature in Hormones
- Vol. 25 (1) , 61-80
Abstract
Background & scope of review: Diabetes mellitus encompasses a spectrum of metabolic disorders characterized by hyperglycemia. The currently most replicated phenotypic clustering approach, introduced by Ahlqvist et al. and validated by Zaharia et al., identified subtypes based on clinical presentation and underlying pathophysiology. This classification aims at predicting complication risk and enabling targeted therapies. Our review explores shared and distinct mechanisms driving complications, focusing on cardiovascular disease and metabolic dysfunction-associated steatotic liver disease (MASLD), both strongly linked to insulin resistance. We also summarize treatment strategies targeting both conditions and outline mechanisms specific to the development of diabetic foot syndrome, exemplifying the continuum from localized to systemic complications. Methods: We conducted a narrative review of human and translational studies, focusing on mechanisms and treatments across the above phenotype-based diabetes subtypes, given their reproducibility across populations. Main results: Diabetes is a multisystem disorder involving a cascade of metabolic disturbances. These include mitochondrial adaptations in key metabolically active tissues contributing to systemic and tissue-specific insulin resistance. Inflammation, inadequate immune responses, oxidative stress, and genetic and environmental factors shape the development of comorbidities whose prevalence varies across subtypes. The interplay between MASLD and diabetes forms a vicious cycle of metabolic abnormalities. Novel treatments show promise in both liver and glycemic endpoints. Conclusion: Phenotype-based diabetes subtypes exhibit distinct underlying pathophysiological mechanisms which shape the development of complications, with insulin resistance serving as the central link. Targeting these pathways can pave the way for personalized diabetes therapies. GraphicalKeywords
Funding Information
- Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
This publication has 105 references indexed in Scilit:
- Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypesDiabetologia, 2025
- The association of sarcopenia and frailty in diabetes‐related foot disease: A 3‐year prospective evaluationJournal of Foot and Ankle Research, 2025
- Reduction of Hepatic Fat Content by Dulaglutide for the Treatment of Diabetes Mellitus: A Two‐Centre Open, Single‐Arm TrialEndocrinology, Diabetes & Metabolism, 2024
- Metabolic–Bariatric Surgery Reduces Pancreatic Cancer Risk: A Meta‐Analysis of Over 3.7 Million Adults, Independent of Type 2 Diabetes StatusDiabetes/Metabolism Research and Reviews, 2024
- Rates of diabetic retinopathy among cluster analysis—identified type 2 diabetic mellitus subgroupsGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- Factors Associated With Diabetic Ketoacidosis at Onset of Type 1 Diabetes Among Pediatric PatientsJAMA Pediatrics, 2022
- Phenotypic and genetic classification of diabetesDiabetologia, 2022
- A novel diabetes typology: towards precision diabetology from pathogenesis to treatmentDiabetologia, 2022
- The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2021
- Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patientsHepatology, 2016